Keryx Biopharma Stock Price (NASDAQ:KERX)

Add to My Stocks
$5.02 $0.14 (2.87%) KERX stock closing price Feb 24, 2017 (Closing)
Keryx Biopharma
24 FEB 2017
amigobulls logo
KERX hand_up
KERX vs S&P 500
Closing Price: Feb 24, 2017
$5.02 ( 2.87%)
S&P 500
2367.3 ( 0.15%)
52 Week Price Range
1 Year Return: 46.11%
Q3 Growth*
Profitable ?
net image
2016 Q3 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Keryx Biopharma Snapshot Video

11 5 2

KERX Stock Details

Prev Close* : $4.88
Market Cap:
Day Low: $4.75
52 Week Low: $3.20
Open: $4.83
Volume: 1265351
Day High: $5.13
52 Week High: $7.80

Latest Stock Market News

Latest Articles

Keryx Biopharma News - From Partners

KERX Stockcharts

View KERX PE ratio, PS ratio stocks charts and compare with peers.
KERX Chart
Note: Compare Keryx Biopharma stock price history with the index and industry peers.

Keryx Biopharma Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Keryx Biopharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

KERX Industry Peers

Company Price Change (%)
Achillion Pharma (ACHN)3.860.38 (8.96%)
Revance (RVNC)20.30.4 (2.01%)
Ardelyx (ARDX)13.50.3 (2.17%)
Akebia Therapeutics (AKBA)9.940.01 (0.1%)
Fibrogen (FGEN)23.60.05 (0.21%)
Affymax (AFFY)0.060 (0%)
Japan Tob Inc (JAPAY)16.890.04 (0.24%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Incyte (INCY)131.219.26 (7.59%)
Sarepta Therapeutics (SRPT)32.021.87 (6.2%)
Stemline Therapeutics (STML)6.850.4 (6.2%)
Bluebird Bio (BLUE)823.7 (4.73%)
Puma Biotech (PBYI)36.21.5 (4.32%)
Sangamo BioSciences (SGMO)40.15 (3.9%)
Epizyme (EPZM)12.150.45 (3.85%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 25, 2017
CompanyPriceChange (%)
Achillion Pharma (ACHN)3.860.38 (8.96%)
Chromadex (CDXC)2.740.13 (4.53%)
Idera Pharma (IDRA)1.670.06 (3.47%)
Inovio Pharma (INO)6.680.22 (3.19%)
VIVUS (VVUS)1.140.03 (2.56%)
Ligand Pharma (LGND)100.382.46 (2.39%)
Compugen (CGEN)4.30.1 (2.27%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 25, 2017

Keryx Biopharma Financial Statements

income statement20152014201320122011
Net Sales Or Revenues13.68M10.82M7M-5M
Net Income-123.14M-111.51M-46.73M-22.72M-28.12M
Total Operating Expense118.1M121.55M54.07M27.07M33.74M
view Keryx Biopharmaceuticals income statement
balance sheet20152014201320122011
Total Assets258.68M103.62M60.76M18.56M43.48M
Total Liabilities171.75M30.14M15.36M8.07M12.44M
Shareholders Equity86.93M73.48M45.4M10.49M31.04M
view Keryx Biopharmaceuticals balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-35.57M2.55M6.4M-1.6M3.4M
Net Cash From (Used By) Operating Activities-127.45M-81M-34.31M-24.76M-22.82M
Increase (Decrease) In Prop Plant And Equipment-2.77M-1.48M-0.34M-0.02M-0.05M
view Keryx Biopharmaceuticals cashflow statement

Keryx Biopharmaceuticals Stock News - Partner Headlines

Keryx Biopharma Stock Message Board

Keryx Biopharma stock lost 2.87 %, and the last close price as of 24 Feb, 2017 is 5.02 for KERX stock. Keryx Biopharma market capitalization is 517.09M and it represents the total market value of KERX stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Keryx Biopharma stock analysis.

Demand for a stock decides its stock market price. For example, if more investors want to buy KERX stock than sell it, then Keryx Biopharma stock price goes up. Conversely, if more investors wanted to sell KERX stock than buy it, there would be greater supply than demand, and the stock price would fall. 1265351 KERX shares were traded yesterday, and Keryx Biopharma stock chart shows that the KERX stock quote hit a day high of 5.13 and day low of 4.75. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Keryx Biopharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.